Date | Speaker | Title | Time starts | Duration |
January 2014 | Graham Atherton | New antifungal drug class reported | 0’00’00secs | |
Pippa Newton | What is Pseudomonas? | 0’31’15secs | ||
Led by Graham Atherton | Entire meeting | 1’45’26secs |
Share this post
Latest News posts
Advice for people with respiratory conditions in winter
October 14, 2019
We Are Undefeatable
October 12, 2019
Aspirin may reduce harmful effects of air pollution on lungs
October 7, 2019
“Aspergillus and me” by Los Trensplantados
September 5, 2019
Side effects of long-term azole therapy
August 6, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video